Traditional Chinese medicine (TCM) offers a fascinating route for investigating possible inhibitors targeting Phosphoserine Aminotransferase 1 (PSAT1) in early-stage ovarian cancer [5]. The gene discussed is PSAT1; the disease is ovarian carcinoma.